Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible...

Area of Science:

• Oncology
• Cell Biology
• Proteomics

Background:

• Bone marrow (BM) angiogenesis is crucial for multiple myeloma (MM) development and progression.
• Understanding novel mechanisms of vessel formation in MM is essential for targeted therapies.

Purpose of the Study:

• To identify novel proteins involved in bone marrow angiogenesis in MM patients.
• To compare proteomic profiles of endothelial cells (ECs) from active MM patients (MMECs), monoclonal gammopathy of undetermined significance (MGECs), and normal subjects.

Main Methods:

• Comparative proteomic analysis of BM ECs from MM, MGUS, and normal individuals.
• Investigated protein expression changes in response to growth factors and MM plasma cell conditioned medium.
• Utilized RNA interference (RNAi) to assess the functional impact of identified proteins on ECs.
• Analyzed protein stabilization and drug-induced effects.

Main Results:

• Four proteins—filamin A, vimentin, α-crystallin B, and 14-3-3ζ/δ—were overexpressed in MMECs and linked to an overangiogenic phenotype.
• Expression of these proteins was enhanced by angiogenic factors and MM plasma cell conditioned medium.
• Silencing these proteins impaired critical EC functions like spreading, migration, and tubular morphogenesis.
• 14-3-3ζ/δ protein showed gradual stabilization from normal to MMECs, suggesting a role in the angiogenic switch.

Conclusions:

• The identified proteins (filamin A, vimentin, α-crystallin B, 14-3-3ζ/δ) are key players in MM-associated bone marrow angiogenesis.
• These proteins are potential novel therapeutic targets for anti-angiogenic strategies in multiple myeloma.
• The findings offer new insights into the mechanisms driving aberrant angiogenesis in the MM bone marrow microenvironment.